The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.
What can we help you find?
The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab, as well as experts that pharmacists can contact with questions regarding buying, selling, and marketing.
Jesica Mills, PharmD, MBA, discusses the opportunities pharmacists have to help their patients with hemp-derived CBD products. This video was filmed at the 2019 NCPA Annual Convention in San Diego.
Four pharmaceutical distributors have agreed to settle federal litigation related to the ongoing opioid epidemic for a collective $260 million, less than a day before a federal trial was set to begin in Ohio.
A new Health Trends study released by Quest Diagnostics has highlighted many physicians' overconfidence in their ability to identify and treat substance misuse, as well as concerns that the drug gabapentin is increasingly being misused.
The agency's move opens the door to more versions of the neuropathic pain reliever.
Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.
OTC case studies for headache treatment during pregnancy and lower-back pain remedies.
Pharmacists can help patients by recommending the most effective and safest therapies.
All 3 are essential in the fight against the opioid crisis, but they need to forge alliances and work together.
Analgesic Alternatives May Help Reduce Unnecessary Exposure to Opioid Medications
Calcitonin gene-related peptide inhibitors are integral to preventing these powerful headaches.
Because of potential adverse reactions, careful product selection for both acute injuries and chronic conditions is key.